Pad Chivukula, Chief Scientific Officer and Chief Operating Officer at Arcturus Therapeutics, discusses the potential of messenger RNA (mRNA) therapeutics in an interview at the TIDES USA conference in San Diego, Calif. Chivukula also highlights the versatility of mRNA technology and its transformative impact on healthcare beyond vaccines. Arcturus is actively developing RNA-based drugs for a range of medical applications, including treatment of rare diseases such as cystic fibrosis.